Vaccine against COVID-19 or against SARS-CoV-2 infection?

被引：1
|
作者：
Rieske, Piotr [1 ,2 ]
机构：
[1] Uniwersytet Med Lodzi, Zaklad Biol Nowotwordow, Ul Zeligowskiego 7-9, PL-90752 Lodz, Poland
[2] Celther Polska, Lodz, Poland
来源：
ALERGOLOGIA POLSKA-POLISH JOURNAL OF ALLERGOLOGY | 2020年 / 7卷 / 03期
关键词：
SARS-CoV-2; vaccine; COVID-19; VIRUS; ANTIBODY; NEUTRALIZATION; MECHANISMS; RESPONSES; PARADIGM;
D O I：
10.5114/pja.2020.97913
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
Article offers analysis of main aspects of SARS-CoV-2/COVID-19 vaccination (severe acute respiratory syndrome coronavirus 2/COVID-19-Coronavirus Disease 2019). Optimal vaccine should protect not only against disease COVID-19 (symptoms), but also against SARS-CoV-2 infection (spreading disease). However, this kind of vaccine - showing highest safety level is extremely difficult to get. Several additional SARS-CoV-2/COVID-19 vaccination issues were addressed in article. For example: serological passports, herd immunity, clinical trials, and role of antibodies and T cells crossreactivities. Article discusses some issues related to vaccination responsibilities.
引用
收藏
页码：131 / 145
页数：15
相关论文
共 50 条
  • [21] An adjuvanted subunit SARS-CoV-2 spike protein vaccine provides protection against Covid-19 infection and transmission
    Tabynov, Kairat
    Turebekov, Nurkeldi
    Babayeva, Meruert
    Fomin, Gleb
    Yerubayev, Toktassyn
    Yespolov, Tlektes
    Li, Lei
    Renukaradhya, Gourapura J.
    Petrovsky, Nikolai
    Tabynov, Kaissar
    NPJ VACCINES, 2022, 7 (01)
  • [22] The continued global battle against SARS-CoV-2 and COVID-19
    Deng, Chu-Xia
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2021, 17 (06): : 1440 - 1442
  • [23] Detection of antibodies against SARS-CoV-2 in patients with COVID-19
    Du, Zhe
    Zhu, Fengxue
    Guo, Fuzheng
    Yang, Bo
    Wang, Tianbing
    JOURNAL OF MEDICAL VIROLOGY, 2020, 92 (10) : 1735 - 1738
  • [24] Antibody responses against SARS-CoV-2 in COVID-19 patients
    Liu, Anding
    Li, Ying
    Peng, Jing
    Huang, Yuancheng
    Xu, Dong
    JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (01) : 144 - 148
  • [25] Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study
    Gram, Mie Agermose
    Emborg, Hanne-Dorthe
    Schelde, Astrid Blicher
    Friis, Nikolaj Ulrik
    Nielsen, Katrine Finderup
    Moustsen-Helms, Ida Rask
    Legarth, Rebecca
    Lam, Janni Uyen Hoa
    Chaine, Manon
    Malik, Aisha Zahoor
    Rasmussen, Morten
    Fonager, Jannik
    Sieber, Raphael Niklaus
    Stegger, Marc
    Ethelberg, Steen
    Valentiner-Branth, Palle
    Hansen, Christian Holm
    PLOS MEDICINE, 2022, 19 (09)
  • [26] A VACCINE AGAINST SARS-COV-2
    Passi, Gouri Rao
    INDIAN PEDIATRICS, 2020, 57 (06) : 593 - 593
  • [27] Antiviral effects and tissue exposure of tetrandrine against SARS-CoV-2 infection and COVID-19
    Liu, Jia
    Wang, Furun
    Wang, Xi
    Fan, Shiyong
    Li, Yufeng
    Xu, Mingyue
    Hu, Hengrui
    Liu, Ke
    Zheng, Bohong
    Wang, Lingchao
    Zhang, Huanyu
    Li, Jiang
    Li, Wei
    Zhang, Wenpeng
    Hu, Zhihong
    Cao, Ruiyuan
    Zhuang, Xiaomei
    Wang, Manli
    Zhong, Wu
    MEDCOMM, 2023, 4 (01):
  • [28] Homologous and Heterologous Covid-19 Booster Vaccinations Against SARS-CoV-2 Infection in the Elderly
    Acer, Omer
    Bahce, Yasemin Genc
    Ozudogru, Osman
    CURRENT MICROBIOLOGY, 2024, 81 (07)
  • [29] Authors' response: Efficacy and effectiveness of COVID-19 vaccines against SARS-CoV-2 infection: More data on asymptomatic SARS-CoV-2 infection
    Harder, Thomas
    Koch, Judith
    Vygen-Bonnet, Sabine
    Kuelper-Schiek, Wiebe
    Pilic, Antonia
    Reda, Sarah
    Scholz, Stefan
    Wichmann, Ole
    EUROSURVEILLANCE, 2021, 26 (35)
  • [30] COVID-19 Therapeutics: An Update on Effective Treatments Against Infection With SARS-CoV-2 Variants
    Padasas, Bill Thaddeus
    Espano, Erica
    Kim, Sang-Hyun
    Song, Youngcheon
    Lee, Chong-Kil
    Kim, Jeong-Ki
    IMMUNE NETWORK, 2023, 23 (02)
12345